Science
Mechanism of Action
This ingredient operates via an androgen-receptor-specific small interfering RNA (siRNA) mechanism. The RNA component, comprising 19 ribonucleotides, is sequence-optimized to bind specifically to the androgen receptor mRNA. Coupled with a 19-deoxyribonucleotide complementary DNA strand, selected from the isoform-common region of human androgen receptor mRNA isoform 1, this conjugate facilitates the precise and effective degradation of its mRNA target, thereby modulating androgen receptor protein expression.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Safety
Safety Profile
No specific safety assessments from CIR, SCCS, or FDA are currently available for STEARYLDISULFIDEHEXYL SH-DNA-3 PEG-45/SH-RNA-2 as a whole. While polyethylene glycols (PEGs), a component of this ingredient, are generally well tolerated by the skin and are not microbiologically sensitive, specific data for this complex molecule is lacking.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This ingredient presents a novel, highly targeted mechanism for modulating androgen receptor expression, but currently lacks comprehensive clinical efficacy and safety data specific to its application in skincare.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources